We are looking for an entrepreneurial CEO for an innovative early stage international digital health company based in Amsterdam. The start-up is a spin-out of an H2020 research project that developed a state of the art, scientific, AI assisted, highly personalised self-management program for non-specific low back pain. The company is to be financed by venture capital. This application is patient centered and potentially will help 550 million people worldwide to take back control of their low back pain.
For more information consult the CEO profile below. Send your application and CV, enquiries or suggestions to email@example.com.
Lipit Technology: FREE YOUR HANDS AND INDEX FINGER. COMPUTER DEVICE CONTROL WITH THE TIP OF YOUR LIP
The LipIt™ headset connects wirelessly to your Bluetooth enabled device, and lets you control your device with your lip. A simple and intuitive lip movement does everything you would otherwise do to control your mouse using your hand. Worn on your head, LipIt™ allows you to be mobile without having to let go of computer or device control. This means that you no longer have to choose between device interaction and all the things you are used to doing with your hands when they are not occupied with controlling a mouse or touch interface. Voice recognition software converts spoken reporting via the microphone into text.
Health Leads considers this patented technology as an important addition to human-computer interaction. It is very intuitive and easy to use, while the applications are numerous: in healthcare for surgeons, dentists and the handicapped, but also in challenging environments in the military, in aviation and in gaming where the cursor via the lip can serve as a third hand.
Health Leads is working together with Lipit inventor Tomas Brusell and his company Lipit Technology in Norway in opening up new markets for this technology and licensing the technology to industry partners.
Contact firstname.lastname@example.org for more information
Baar, Switzerland, Amsterdam The Netherlands, March 8, 2017